Youtube
SUNPHARMA

Sun Pharmaceutical Industries Share PriceSun Pharmaceutical Industries

₹1028.15
20.55 (2.04%)
  • Advice
  • Hold
As on 05 February, 2023 | 16:17 BSE: 524715 NSE: SUNPHARMA

Sun Pharmaceutical Industries Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Sun Pharmaceutical Industries

Start SIP

Sun Pharmaceutical Industries Share Price

  • Over 1 Month 1.89%
  • Over 3 Month -1.54%
  • Over 6 Month 14.62%
  • Over 1 Year 16.37%

Sun Pharmaceutical Industries Key Statistics

P/E Ratio 58.6
PEG Ratio -1.7
Market Cap Cr 246,688
Price to Book Ratio 4.8
EPS -5.6
Dividend 1
Relative Strength Index 51.12
Money Flow Index 42.43
MACD Signal 6.58
Average True Range 22.16

Sun Pharmaceutical Industries Investment Rating

  • Master Rating:
  • Sun Pharm.Industries has an operating revenue of Rs. 42,401.77 Cr. on a trailing 12-month basis. An annual revenue growth of 15% is outstanding, Pre-tax margin of 12% is healthy, ROE of 6% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 9% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It has recently broken out of a base in its weekly chart and is trading around -3% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 64 which is a FAIR score but needs to improve its earnings, a RS Rating of 64 which is FAIR indicating the recent price performance, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 95 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Overall, the stock definitely has some strength, you may want to examine it in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Sun Pharmaceutical Industries Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 4,5505,2854,8623,988
Operating Expenses Qtr Cr 3,6463,6223,4833,007
Operating Profit Qtr Cr 9991,6631,4501,000
Depreciation Qtr Cr 430384375354
Interest Qtr Cr 131938791
Tax Qtr Cr 191525486
Net Profit Qtr Cr 4871,2131,012-1,286

Sun Pharmaceutical Industries Technicals

EMA & SMA

Current Price
₹1028.15
20.55 (2.04%)
  • Bullish Moving Average
  • ___
  • 12
  • Bearish Moving Average
  • ___
  • 4
  • 20 Day
  • 1027.78
  • 50 Day
  • 1016.64
  • 100 Day
  • 992.24
  • 200 Day
  • 947.43
  • 20 Day
  • 1030.97
  • 50 Day
  • 1018.61
  • 100 Day
  • 994.22
  • 200 Day
  • 935.77

Sun Pharmaceutical Industries Resistance and Support

PIVOT
₹1005.44
Resistance
First Resistance 1017.87
Second Resistance 1028.14
Third Resistance 1040.57
RSI 51.12
MFI 42.43
MACD Single Line 6.58
MACD 3.64
Support
First Resistance 995.17
Second Resistance 982.74
Third Resistance 972.47

Sun Pharmaceutical Industries Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 2,548,030 167,125,288 65.59
Week 3,685,380 220,090,894 59.72
1 Month 2,378,372 148,386,620 62.39
6 Month 2,746,690 159,774,986 58.17

Sun Pharmaceutical Industries Result Highlights

Sun Pharmaceutical Industries Synopsis

NSE-Medical-Generic Drugs

Sun Pharma. is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 15585.98 Cr. and Equity Capital is Rs. 239.93 Cr. for the Year ended 31/03/2022. Sun Pharmaceutical Industries Ltd. is a Public Limited Listed company incorporated on 01/03/1993 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ1993PLC019050 and registration number is 019050.
Market Cap 246,688
Sales 18,871
Shares in Float 110.37
No of funds 1052
Yield 1.02
Book Value 10.03
U/D Vol ratio 0.7
LTDebt / Equity 20
Alpha 0.06
Beta 0.56

Sun Pharmaceutical Industries

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 54.48%54.48%54.48%
Mutual Funds 12.46%12.22%11.84%
Insurance Companies 5.55%6.36%7.52%
Foreign Portfolio Investors 16.87%16%14.95%
Financial Institutions/ Banks 0.04%0.15%0.22%
Individual Investors 5.76%5.91%6.31%
Others 4.84%4.88%4.68%

Sun Pharmaceutical Industries Management

Name Designation
Mr. Israel Makov Chairman, Non Ind & Non Exe Director
Mr. Dilip S Shanghvi Managing Director
Mr. Sailesh T Desai Whole Time Director
Mr. Kalyanasundaram Subramanian Whole Time Director
Mr. Sudhir V Valia Non Exe.Non Ind.Director
Dr. Pawan Goenka Non Exe. & Ind. Director
Mr. Rama Bijapurkar Non Exe. & Ind. Director
Mr. Gautam Doshi Ind. Non-Executive Director

Sun Pharmaceutical Industries Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Sun Pharmaceutical Industries Corporate Action

Date Purpose Remarks
2023-01-31 Quarterly Results & Interim Dividend
2022-11-01 Quarterly Results
2022-07-29 Quarterly Results
2022-05-30 Audited Results & Final Dividend
2022-01-31 Quarterly Results & Interim Dividend
Date Purpose Remarks
2023-02-08 INTERIM Rs.7.50 per share(750%)Interim Dividend
2022-08-22 FINAL Rs.3.00 per share(300%)Final Dividend
2022-02-10 INTERIM Rs.7.00 per share(700%)Interim Dividend
2021-02-10 INTERIM Rs.5.50 per share(550%)Interim Dividend

Sun Pharmaceutical Industries MF Shareholding

Name Amount(cr)
SBI Nifty 50 ETF 154851
SBI S&P BSE Sensex ETF 85383
SBI Equity Hybrid Fund Regular Payout Inc Dist cum Cap Wdrl 56710
HDFC Balanced Advantage Fund Growth 51027
ICICI Prudential Balanced Advantage Fund Growth 44634

Sun Pharmaceutical Industries Videos

Sun Pharmaceutical Industries FAQs

What is Share Price of Sun Pharmaceutical Industries ?

Sun Pharmaceutical Industries share price is ₹1028 As on 05 February, 2023 | 16:03

What is the Market Cap of Sun Pharmaceutical Industries ?

The Market Cap of Sun Pharmaceutical Industries is ₹246687.6 Cr As on 05 February, 2023 | 16:03

What is the P/E ratio of Sun Pharmaceutical Industries ?

The P/E ratio of Sun Pharmaceutical Industries is 58.6 As on 05 February, 2023 | 16:03

What is the PB ratio of Sun Pharmaceutical Industries ?

The PB ratio of Sun Pharmaceutical Industries is 4.8 As on 05 February, 2023 | 16:03

What is the future of Sun Pharmaceutical Industries (Sun Pharma)?

Sun Pharmaceutical Industries (Sun Pharma) has an operating revenue of INR 36,704.43 Cr. on a trailing 12-month basis. Annual revenue growth of 3% is not great, Pre-tax margin of 8% is okay. Institutional holding has gone up in the last reported quarter is a positive sign. Analyst Recommendation on Sun Pharmaceutical Industries (Sun Pharma): HOLD

Who is the Managing Director of Sun Pharmaceutical Industries (Sun Pharma)?

Dilip Shanghvi is the Managing Director of Sun Pharmaceutical Industries (Sun Pharma).

What is the ROE of Sun Pharmaceutical Industries (Sun Pharma)?

The ROE of Sun Pharmaceutical Industries (Sun Pharma) is 6% which is fair but needs improvement.

Is Sun Pharmaceutical Industries (Sun Pharma) Debt to Equity Ratio?

Sun Pharmaceutical Industries (Sun Pharma) has a reasonable debt to equity of 2%, which signals a healthy balance sheet.

What is the PE ratio of Sun Pharmaceutical Industries (Sun Pharma)?

The PE ratio of Sun Pharmaceutical Industries (Sun Pharma) is 81.5.

Q2FY23